We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byRonald Ireland
Modified about 1 year ago
TEMPLATE DESIGN © 2008 www.PosterPresentations.com Twin Pregnancies with co-existing complete hydatiform mole(CHM) and viable fetus Dr Lucas Luk, Dr Haris Suharjono, Dr Nicholas Ngeh Sarawak General Hospital, O&G Department Introduction The incidence of twin pregnancy with hydatidiform mole is 1 in 20 000 to 100 000 pregnancies. 1,2 The majority of twin pregnancies involving a mole are those combining a Complete Hydatidiform Mole (CHM) and coexistent normal placenta and fetus. 1,2 Twin pregnancies involving a Partial Hydatidiform Mole(PHM) and a coexistent normal gestational sac are rarely reported, while twin pregnancies where both fetuses are affected by PHM are exceptionally rare. 1 Case Study Discussion Distinguishing CHM in twin pregnancies from PHM in twin pregnancy is essential, as the former offers a much better possibility of a healthy newborn. Conclusions References Women diagnosed with twin pregnancy with CHM and co- existing viable fetus should be referred to a maternal fetal unit for counseling and further management. In view of the multiple maternal and fetal risks involved, if continuation of pregnancy is desired, regular screening for possible maternal complications and assessment of fetal well-being should be performed. OPTIONAL LOGO HERE 1)Wee L, Jauniaux E. Prenatal diagnosis and management of twin pregnancies complicated by a co-existing molar pregnancy. Prenat Diagn 2005;25:772–6. 2)Sebire NJ, Foskett M, Paradinas FJ, Fisher RA, Francis RJ, Short D, et al. Outcome of twin pregnancies with complete hydatidi-form mole and healthy co-twin. Lancet 2002;359:2165–6. 3)Francisco Montes-de-Oca-Valero, Lena Macara and Adel Shaker; Twin pregnancy with a complete hydatidiform mole and co-existing fetus following in-vitro-fertilization: Case Report; human Reproduction (1999) 14 (11):2905- 2907 4)RCOG Green-top Guideline No.38 February 2010 5)Savage P. Molar pregnancy. The Obstetrician & Gynaecologist 2008;10:3–8. 6)Fox H. 1997. Pathology of the Placenta (2nd edn). W. B. Saunders:London. 7)Szulman AE, Surti U. 1978b. The syndromes of hydatidiform mole.II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 132 : 22– 27. While uterine size is a prognosticator of PTD in a singleton molar pregnancy, the size of the mole does not appear to affect the development of PTD in twin molar pregnancies. 3,4 Conversely, an increasing MShCG level and the presence of bilateral theca lutein cysts might indicate an increased risk of maternal complications including PTD. 1 In this way, biochemical markers are useful in helping to manage molar pregnancies. We report a case of twin pregnancy with coexisting CHM, and a viable fetus. A 21 years old primigravida at 11 weeks gestation was referred to us for second opinion due to abnormal scan finding. Transabdominal scan demonstrated a normal fetus and placenta next to a mass, with vesicular pattern (Images 1 & 2). Diagnosis was viable fetus with coexisting molar pregnancy. The patient was counseled regarding the scan findings and possible management options. She elected for termination of pregnancy and subsequent histopathological report confirmed our diagnosis. Complete molar pregnancies are diploid and androgenic in origin, with no evidence of fetal tissue. 3-6 The chromosome count is usually (75-80%) 46XX, resulting from a single sperm duplicating within an empty oocyte. 4 Occasionally (20-25%), a 46XY genotype can occur, when an empty ovum is fertilized by 2 sperm. 4,7 In the case of PHM in a twin pregnancy, 2 fetuses will be seen, one structurally normal and the other likely to show signs of growth restriction and structural anomalies. Ultrasound is an accurate diagnostic tool at the end of the first trimester. 1,2 However, few reports of such pregnancies have been documented and fetal viability is poor. However, current evidence suggests there is no increased risk of developing persistent trophoblastic disease(1/3) after carrying a twin CHM pregnancy to term, as compared to early termination. Outcome after chemotherapy is also unaffected. 1,4 Beta-human chorionic gonadotrophin (hCG) Alpha Feto- Protein (AFP) Pregnancy Associated Plasma Protein A (PAPP-A) Pregnancy Specific glycoprotein 1 (SP1) Singleton CHM ↑↑ ↓↓ ↑ ↑ Twin CHM ↑↑ N/↑ ↑ ↑ A classical mole may coexist with a normal fetus and placenta in cases of molar transformation of one ovum in a dizygotic dichorionic twin pregnancy and very rarely, in a monochorioinic one. CHM in a twin pregnancy will appear as a normal fetus and placenta next to a molar mass (vesicular sonographic pattern) on ultrasound scan. Biochemical markers can be useful in diagnosing and distinguishing between singleton and twin CHM pregnancy: Due to the influence of high maternal serum hCG, bilateral multicystic ovaries are found in ~25% of patients with CHM pregnancies, as a result of theca lutein cystic transformation. In 90% of PHM moles, the chromosome makeup is triploid: 2 paternal and one maternal, as a result of 2 sperm simultaneously entering an oocyte. 4,5,7 Rarely, tetraploidy occurs. In PHM, there is a combination of a fetus with localized placental hydatidiform changes. Histologically, this is characterized by focal swelling of the villous tissue, focal trophoblastic hyperplasia and embryonic or fetal tissue. Twin CHM pregnancy Preeclampsia Toxaemia (4-20%) Heavy Vaginal Bleeding (~50%) Thecal Luteal Cysts (~25%) Hyperthyroidism (~5%) Live Birth Rates (25-40%) Early Fetal Loss (40%) Preterm Delivery (36%) In those continuing with pregnancy, there are increased maternal risks 1,2,4 : Generally, many are still uneasy about twin pregnancy with CHM and co-existing viable fetus, just like our patient. In documented twin pregnancies as such, ~50% opt for termination of pregnancy. 1 An anticipated rise in the incidence of twin molar pregnancies with co-existing viable fetus can also be expected with the advent of molecular genetics and the progress of biochemical diagnostic tools. However, a high index of suspicion is still required to facilitate early diagnosis and appropriate management of such pregnancies. 1 2 Alternatively, if the co-existing fetus appears sonographically normal and pregnancy is pursued, determinations of allele inheritance can be performed after 15weeks through amniocentesis, or fetal blood sampling 1. If the fetus is euploid it is suggestive of twin pregnancy with CHM and normal, viable fetus, rather than PHM. Provided the mother is clinically well, pregnancy may continue but she should be followed up fortnightly with serial ultrasound for growth assessment and cervical length monitoring to assess the risk of preterm labour. With more women now deferring pregnancies till later in life, the risks of hydatidiform molar pregnancies is likely to increase. Older mothers are known to be at increased risk of problems during meiosis, due to poorer oocyte quality. 3 Moreover, as in- vitro fertilization becomes a rising trend amongst women at the later stages of their reproductive life, the number of twin pregnancies with co-existing mole and viable fetus should increase. Chorionic villus sampling with DNA polymorphism studies can be employed to determine the parental aetiology of the fetal chromosomes. This helps differentiate between CHM with co- existing normal twin and PHM in early pregnancy. 1,4 The genotype of a CHM, in contrast to a PHM, is entirely of paternal origin. The diagnosis is made either by direct comparison with the paternal alleles when available, or by exclusion of the maternal alleles. 1 This totally androgenous conceptus consists of a generalized swelling of the villous tissue, diffuse trophoblastic hyperplasia, giving rise to the classical ‘bunch of grape’ appearance on ultrasound, and no fetal or embryonic tissue. 7
Trophoblastic disease -This is a group of disorders characterized by -This is a group of disorders characterized by 1-abnormal placental development. 1-abnormal.
Non-molar triploidy followed by triploid molar pregnancy in a patient with recurrent miscarriage Introduction Recurrent miscarriage, defined as loss of.
Prenatal diagnosis Dr Neda Bogari. It’s the ability to detect abnormalities in an unborn child. Prenatal diagnosis is an option which is chosen by many.
GESTATIONAL TROPHOBLASTIC TUMORS (GTT). *It is a diverse group of tumors 80 – 90% Benign * That includes Benign Hydatidiform mole to Choriocarcinoma *It.
The term gestational trophoblastic disease describes a group of inter-related disease, including complete and partial molar pregnancy, choriocarcinoma,
The Role of Prenatal screening as part of Routine Obstetric Care Dr Sarah Pixton O & G Registrar 4 th June 2014.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Objectives: Our aim was to find the sensitivity of transvaginal ultrasonography (TVUS) in diagnosing women with gestational trophoblastic disease (GTD).
Gestational Trophoblastic Disease for Undergraduates Max Brinsmead MB BS PhD May 2015.
1 Gestational Trophoblastic Diseases DR. SAMAA NAZER Assistant Professor of Obstetrics & Gynecology Jeddah, Saudi Arabia.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Session 12 Medical Genetics Prenatal Testing and Reproductive Genetics.
First Trimester Screening Shannon N. Barringer, MS, CGC Chairman, Department of Genetic Counseling UAMS, College of Health Related Professions.
Gestational Trophoblastic Disease Max Brinsmead MB BS PhD March 2015.
Second-trimester maternal serum screening. Counseling for all patients Information about the screening tests offered – Detection rate – False-positive.
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
MULTIPLE PREGNANCY King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.
GESTATIONAL TROPHOBLASTIC TUMORS (GTT) GESTATIONAL TROPHOBLASTIC Disease (GTD)
Disorders of early pregnancy. Ectopic Pregnancy - Means implantation of the fetus in any site other than a normal intrauterine location. - The most common.
Premature Delivery Premature Rupture of Membrane Prolonged Pregnancy, Multiple Pregnancy Women Hospital, School of Medical, ZheJiang University Yang Xiao.
Genetics and Primary Care What’s New in Maternal Serum Screening?
Amniocentesis and CVS Dr. Joseph Har-Toov Lis Maternity Hospital Tel-Aviv, Israel.
PRENATAL DIAGNOSIS OF A LARGE PLACENTAL CYST WITH INTRACYSTIC HEMORRHAGE OB8.
Gestational Trophoblastic Disease Current management.
TEMPLATE DESIGN © Reduced Fetal Movements as a Predictor of Fetal Compromise Dr. Meenu Sharma Lancashire Teaching Hospital.
ECTOPIC PREGNANCY is implantation of the fertilized ovum in any site other than the normal uterine location. Incidence: 1% of pregnancies. In 90% of these.
Hydatidiform Mole Mamdoh Eskandar FRCSC Gestational trophoblastic Disease Molar pregnancy Molar pregnancy -Complete hydatiditform mole -Incomplete hydatiditform.
Part 1. Cornerstones of diagnosis are: history and examination hCG transvaginal ultrasound.
Bleeding in Early Pregnancy Max Brinsmead PhD FRANZCOG February 2015.
Pregnancy & Newborn Screening Developments Changes to the Down’s Syndrome Screening Programme.
TEMPLATE DESIGN © Down syndrome in both Dichorionic Twins: A case Report B. Towobola, S. Bazuaye, J. Obrycki Causeway.
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
1 st Trimester AIUM/ACOG/ACR Guidelines Transabdominal and/or transvaginal imaging Appropriate labeling required Uterus, including the cervix and.
Gestational Trophoblastic Disease. Definitions Gestational Trophoblastic Neoplasia (GTN) chorioadenoma destruens, metastasizing mole, choriocarcinoma.
Ultrasound in obstetrics By Dr. Khattab KAEO Assis. Prof. of Obstetrics and Gynaecology Faculty of Medicine, Al-Azhar University, Damietta.
Gestational trophoblastic disease GTD. Gestational trophoblastic disease (GTD) Is term applied for a group of pregnancy- related disorders arising from.
TEMPLATE DESIGN © Retrospective Analysis of Amniocentesis in UKMMC ZulidaR, MAJamil Universiti Putra Malaysia, UPM Serdang,
七年制 GTD1 Gestational Trophoblastic Disease DI WEN M.D., Ph.D., Professor & Chairman Department Of Obstetrics & Gynecology Renji Hospital Affiliated.
Biochemical tests and ‘marker chemicals’. Learning Outcomes The health of mother and foetus can be monitored by biochemical tests that detect the normal.
Prevention of Birth Defects An Overview of Primary and Secondary Strategies.
Higher Human Biology Unit 2 Physiology & Health KEY AREA 4: Ante- and Postnatal Screening.
Prenatal diagnosis (PND) in Joubert syndrome Dan Doherty, MD/PhD.
Problems During Prenatal Development & Prenatal Testing.
Chapter 7 Genetic and Developmental Diseases. Review of Structure and Function Fertilization is the uniting of a sperm and ovum resulting in 23 pairs.
History First identified as a cytogenetic syndrome in syndrome in ,XX,+13 47,XY, + 13 ♀ ♂
UOG Journal Club: August 2011 Systemic labeling of twin pregnancies on ultrasound T Dias, S Ladd, S Mahsud-Dornan, A Bhide, A T Papageorghiou and B Thilaganathan.
TEMPLATE DESIGN © ‘’A profile of cases of Gestational Trophoblastic Neoplasia at a large tertiary centre in Dubai” Authors.
Genetic Testing in Pregnancy Lisbeth M. Lazaron, MD March 2013.
Follow-up scans later in pregnancy improved accreta detection but provided useful information in only a limited number of cases. Of the individual markers,
Vesicular Mole Dr. MOHAMMED ABDALLA EGYPT, DOMIAT G. HOSPITAL.
© 2017 SlidePlayer.com Inc. All rights reserved.